EFFICIENCY OF TARGETED THERAPY USED IN THE HETEROGENEOUS POPULATION OF PATIENTS WITH METASTATIC KIDNEY CANCER
Most clinical trials were conducted on a thoroughly selected population of patients with mainly clear-cell metastatic renal-cell carcinoma (mRCC) without brain metastases and with a good somatic status. In routine clinical practice, the population of patients with mRCC is more heterogeneous: there a...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2014-08-01
|
Series: | Onkourologiâ |
Subjects: | |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/316 |